These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 12504780

  • 1. Antagonist effect of pseudohypericin at CRF1 receptors.
    Simmen U, Bobirnac I, Ullmer C, Lübbert H, Berger Büter K, Schaffner W, Schoeffter P.
    Eur J Pharmacol; 2003 Jan 05; 458(3):251-6. PubMed ID: 12504780
    [Abstract] [Full Text] [Related]

  • 2. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R, Koyabu N, Morimoto S, Shoyama Y, Ohtani H, Sawada Y.
    Drug Metab Dispos; 2005 Apr 05; 33(4):547-54. PubMed ID: 15640377
    [Abstract] [Full Text] [Related]

  • 3. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
    Laggner H, Schreier S, Hermann M, Exner M, Mühl A, Gmeiner BM, Kapiotis S.
    Free Radic Res; 2007 Feb 05; 41(2):234-41. PubMed ID: 17364950
    [Abstract] [Full Text] [Related]

  • 4. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's wort (Hypericum perforatum CV new stem).
    Murch SJ, Rupasinghe HP, Saxena PK.
    Planta Med; 2002 Dec 05; 68(12):1108-12. PubMed ID: 12494339
    [Abstract] [Full Text] [Related]

  • 5. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J, Klejdus B, Kubán V.
    Ceska Slov Farm; 2007 Apr 05; 56(2):62-6. PubMed ID: 17619301
    [Abstract] [Full Text] [Related]

  • 6. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
    Wang EJ, Barecki-Roach M, Johnson WW.
    J Pharm Pharmacol; 2004 Jan 05; 56(1):123-8. PubMed ID: 14980009
    [Abstract] [Full Text] [Related]

  • 7. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection.
    Rückert U, Likussar W, Michelitsch A.
    Phytochem Anal; 2007 Jan 05; 18(3):204-8. PubMed ID: 17500362
    [Abstract] [Full Text] [Related]

  • 8. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
    Butterweck V, Christoffel V, Nahrstedt A, Petereit F, Spengler B, Winterhoff H.
    Life Sci; 2003 Jun 20; 73(5):627-39. PubMed ID: 12770617
    [Abstract] [Full Text] [Related]

  • 9. St. John's wort: role of active compounds for its mechanism of action and efficacy.
    Butterweck V, Schmidt M.
    Wien Med Wochenschr; 2007 Jun 20; 157(13-14):356-61. PubMed ID: 17704987
    [Abstract] [Full Text] [Related]

  • 10. Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition deficit: a possible role of hyperforin.
    Tadros MG, Mohamed MR, Youssef AM, Sabry GM, Sabry NA, Khalifa AE.
    Behav Brain Res; 2009 May 16; 199(2):334-9. PubMed ID: 19136030
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
    Obach RS.
    J Pharmacol Exp Ther; 2000 Jul 16; 294(1):88-95. PubMed ID: 10871299
    [Abstract] [Full Text] [Related]

  • 12. Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines.
    Hostanska K, Reichling J, Bommer S, Weber M, Saller R.
    Eur J Pharm Biopharm; 2003 Jul 16; 56(1):121-32. PubMed ID: 12837490
    [Abstract] [Full Text] [Related]

  • 13. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
    Schulz HU, Schürer M, Bässler D, Weiser D.
    Arzneimittelforschung; 2005 Jul 16; 55(10):561-8. PubMed ID: 16294501
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous determination of the predominant hyperforins and hypericins in St. John's Wort (Hypericum perforatum L.) by liquid chromatography.
    Gray DE, Rottinghaus GE, Garrett HE, Pallardy SG, Gray DE, Rottinghaus GE, Garrett HE, Pallardy SG.
    J AOAC Int; 2000 Jul 16; 83(4):944-9. PubMed ID: 10995119
    [Abstract] [Full Text] [Related]

  • 15. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
    Schulz HU, Schürer M, Bässler D, Weiser D.
    Arzneimittelforschung; 2005 Jul 16; 55(1):15-22. PubMed ID: 15727160
    [Abstract] [Full Text] [Related]

  • 16. Researching the antidepressant actions of Hypericum perforatum (St. John's wort) in animals and man.
    Franklin M, Cowen PJ.
    Pharmacopsychiatry; 2001 Jul 16; 34 Suppl 1():S29-37. PubMed ID: 11518072
    [Abstract] [Full Text] [Related]

  • 17. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
    Butterweck V, Winterhoff H, Herkenham M.
    Mol Psychiatry; 2001 Sep 16; 6(5):547-64. PubMed ID: 11526469
    [Abstract] [Full Text] [Related]

  • 18. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
    Gobbi M, Moia M, Pirona L, Morizzoni P, Mennini T.
    Pharmacopsychiatry; 2001 Jul 16; 34 Suppl 1():S45-8. PubMed ID: 11518075
    [Abstract] [Full Text] [Related]

  • 19. St. John's wort.
    Lawvere S, Mahoney MC.
    Am Fam Physician; 2005 Dec 01; 72(11):2249-54. PubMed ID: 16342849
    [Abstract] [Full Text] [Related]

  • 20. Determination of hyperforin, hypericin, and pseudohypericin in human plasma using high-performance liquid chromatography analysis with fluorescence and ultraviolet detection.
    Bauer S, Störmer E, Graubaum HJ, Roots I.
    J Chromatogr B Biomed Sci Appl; 2001 Dec 05; 765(1):29-35. PubMed ID: 11817306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.